THERESA CALDERON: Open Payments
NPI 1083965347 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 20 payments from 11 companies in 2025. Trend: 2023 $114 · 2024 $545 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $104 |
| Edwards Lifesciences Corporation | 2 | $61 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $32 |
| PFIZER INC. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| ABIOMED | 1 | $22 |
| Antares Pharma, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, GVOKE HYPOPEN, SAPIEN 3 Ultra RESILIA, JARDIANCE, GEMTESA, PREVNAR 20, XIFAXAN, Wegovy.
Industry payments across SC — which companies pay providers there.
